Atomoxetine clinical trials
Also written LY139603.
How each study uses atomoxetine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the atomoxetine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 26 Nov 2002 · STRATTERA · NDA 021411 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
140 studies that test it; most in 2005 (26)
| Year | Studies |
|---|---|
| 1997 | 1 |
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 12 |
| 2004 | 23 |
| 2005 | 26 |
| 2006 | 11 |
| 2007 | 9 |
| 2008 | 9 |
| 2009 | 5 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 6 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 54 · Other 88
Eli Lilly and Company (50) · Massachusetts General Hospital (6) · Brigham and Women's Hospital (5) · Icahn School of Medicine at Mount Sinai (5) · Yale University (5) · University of Arizona (2) · University of Calgary (2) · University of Maryland, Baltimore (2)
Often tested with
Tested in the same studies.
Methylphenidate (11) · Oxybutynin (5) · Acetazolamide (3) · Indomethacin (2) · Midodrine (2) · Modafinil (2) · Octreotide (2) · Rivastigmine (2)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 4, 1 in phase 3
Studies that test atomoxetine, phase 3 first.
- Jul 2027Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal ApproachPhase 3 · Radboud University Medical Center
- Dec 2026Atomoxetine and DAW2022 on OSA SeverityPhase 1/2 · Brigham and Women's Hospital
- Oct 2027Study of the Effects of Atomoxetine on MotivationPhase 4 · University of Oxford
- Nov 2027Role of the Noradrenergic System in the Regulation of Learning Dynamics: Evaluation of the Effect of a Low-dose Selective Noradrenaline Reuptake Inhibitor (NOISYXETINE)Not applicable · Centre Hospitalier St Anne
Studies
Open first, then newest update. How each study uses atomoxetine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 142
- Study of the Effects of Atomoxetine on MotivationNot yet recruitingPhase 4University of OxfordNCT07771595Written as Atomoxetine
- Atomoxetine in Melanocortin Obesity SyndromeRecruitingPhase 2Icahn School of Medicine at Mount SinaiNCT06899178Written as Atomoxetine
- Rescue Pharmacotherapy for OSARecruitingPhase 1/2Brigham and Women's HospitalNCT05293600Written as Atomoxetine and eszopiclone
- Atomoxetine and DAW2022 on OSA SeverityRecruitingPhase 1/2Brigham and Women's HospitalNCT05350215Written as Atomoxetine Oral Capsule [Strattera]
- Atomoxetine and Executive Function in PTSDRecruitingPhase 4VA Office of Research and DevelopmentNCT06573970Written as Atomoxetine
- Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal ApproachRecruitingPhase 3Radboud University Medical CenterNCT07316296Written as Atomoxetine
- Role of the Noradrenergic System in the Regulation of Learning Dynamics: Evaluation of the Effect of a Low-dose Selective Noradrenaline Reuptake Inhibitor (NOISYXETINE)RecruitingNot applicableCentre Hospitalier St AnneNCT07239791Written as Atomoxetine
- Evaluating the Efficacy of Atomoxetine in Reducing Primary Nocturnal Enuresis in Children With ADHD: A Randomized, Placebo-Controlled StudyNot yet recruitingEarly Phase 1Tanta UniversityNCT06841666Written as Atomoxetine
- Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD RiskRecruitingPhase 4Icahn School of Medicine at Mount SinaiNCT03781765Written as Atomoxetine
- Study of Atomoxetine in the Prevention of Vasovagal SyncopeRecruitingPhase 3University of CalgaryNCT05159687Written as Atomoxetine Hydrochloride
- Identifying Sleep Apnea Patients That Best Respond to Atomoxetine Plus Oxybutynin TherapyRecruitingPhase 1/2Brigham and Women's HospitalNCT05550246Written as Atomoxetine
- Role of Coenzyme Q in ADHD in ChildrenRecruitingPhase 3Sherief Abd-ElsalamNCT04216186Written as Atomoxetine
- Treatment of Orthostatic IntoleranceActive, not recruitingPhase 1/2Satish R. RajNCT00262470Written as Atomoxetine
- A Novel Pharmacological Therapy for Obstructive Sleep ApneaCompletedPhase 2Brigham and Women's HospitalNCT03919955Written as Atomoxetine
- Pharmacological Treatment Targeting Endotypic Traits of Obstructive Sleep ApneaCompletedPhase 4China Medical University HospitalNCT06295562Written as Atomoxetine 80mg combined with oxybutynin 5mg
- Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down SyndromeActive, not recruitingPhase 2University of ArizonaNCT05933603Written as Atomoxetine and Oxybutynin (ato-oxy)
- TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's DiseaseCompletedEarly Phase 1Hubert FernandezNCT02879136Written as Atomoxetine
- Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep ApneaCompletedPhase 1/2Brigham and Women's HospitalNCT05944965Written as Atomoxetine 80 mg plus Oxybutynin 5 mg
- Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With AutismCompletedPhase 3Massachusetts General HospitalNCT00498173Written as Atomoxetine
- Medications for Obstructive Sleep Apnea In Children With Down SyndromeCompletedPhase 2University of ArizonaNCT04115878Written as Atomoxetine and oxybutynin (ato-oxy)
See all 142 studies that test atomoxetine →
Given beside what is tested · 3 — atomoxetine is usual care or a partner of the new treatment
- Continuation Protocol for Obstructive Sleep Apnea (OSA)Enrolling by invitationPhase 3ApnimedNCT06566820Written as Aroxybutynin and Atomoxetine
- Black Seed Oil in ADHDNot yet recruitingPhase 2Ain Shams UniversityNCT06542887Written as Atomoxetine
- Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHDCompletedPhase 4State University of New York at BuffaloNCT00918567Written as atomoxetine
As the comparator · 17 — what is tested is compared with atomoxetine
- An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's DiseaseRecruitingPhase 3University College, LondonNCT07724132Written as Atomoxetine
- Parallel Arm Trial of AD109 and AD504 In Patients With OSACompletedPhase 2ApnimedNCT05071612Written as Atomoxetine Hydrochloride
- A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)CompletedPhase 4ShireNCT04085172Written as Atomoxetine hydrochloride
- The Neuroprotective Effects of Methylphenidate and Atomoxetine in Children With ADHD: A Lipidomic StudyCompletedNot applicableNational Taiwan University HospitalNCT03936491Written as Atomoxetine
- Crossover Trial of AD036 in Obstructive Sleep ApneaCompletedPhase 2ApnimedNCT04445688Written as Atomoxetine
- Study for Efficacy and Dose Escalation of AD313 + Atomoxetine (SEED)CompletedPhase 1/2ApnimedNCT05101122Written as Dosing 1: Atomoxetine
- Crossover Trial of AD109 in Obstructive Sleep ApneaCompletedPhase 2ApnimedNCT04580394Written as Atomoxetine
- The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity DisorderCompletedPhase 2Otsuka Pharmaceutical Development & Commercialization, Inc.NCT03324581Written as Atomoxetine
- Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedPhase 3ShireNCT01244490Written as Atomoxetine Hydrochloride
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to MethylphenidateCompletedPhase 3ShireNCT01106430Written as Atomoxetine Hydrochloride
- Analog Classroom Study Comparison of ADDERALL XR With STRATTERA in Children Aged 6-12 With ADHDCompletedPhase 4ShireNCT00506727Written as Atomoxetine hydrochloride
- Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder.WithdrawnPhase 2PfizerNCT00562055Written as Atomoxetine
- EAA/Therapy for Treating Children With ADHDStatus unknownNot applicableSamsung Medical CenterNCT02482649Written as Atomoxetine
- A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedPhase 2Johnson & Johnson Pharmaceutical Research & Development, L.L.C.NCT00880217Written as Atomoxetine 80 mg/d
- A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedPhase 2AbbVie (prior sponsor, Abbott)NCT00528697Written as atomoxetine
- Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) ChildrenCompletedPhase 4Peking UniversityNCT01065259Written as Atomoxetine
- A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedPhase 2AbbottNCT00429091Written as atomoxetine
Codes
What other systems call atomoxetine · ClinicalTrials.gg INT006579
- MeSH (NLM) D000069445Atomoxetine HydrochlorideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) ASW034S0B8ATOMOXETINEConfirmed FDA, NLM, Wikidata
- RxNorm 38400Confirmed FDA, Wikidata
- Wikidata Q417240atomoxetineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C74141AtomoxetineOne source FDA
- DrugBank DB00289One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069445 | Atomoxetine Hydrochloride | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | ASW034S0B8 | ATOMOXETINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 38400 | — | Confirmed FDA, Wikidata |
| Wikidata | Q417240 | atomoxetine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C74141 | Atomoxetine | One source FDA |
| DrugBank | DB00289 | — | One source Wikidata |
Also registered as atomoxetine hydrochloride (UNII 57WVB6I2W0 · RxNorm 353103).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.